Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liam R Brunham

Showing results (51-60 of 156) with videos related to

Pageof 16
Sort By:
European Heart Journal|August 28, 2023
Recommendations for statin management in primary prevention: disparities among international risk scoresG B John Mancini, Arnold Ryomoto, Eunice Yeoh, et al.
Cardiovascular Research|June 8, 2018
Role of genetics in the prediction of statin-associated muscle symptoms and optimization of statin use and adherenceLiam R Brunham, Steven Baker, Andrew Mammen, et al.
The Canadian Journal of Cardiology|August 29, 2021
Familial Hypercholesterolemia, Familial Combined Hyperlipidemia, and Elevated Lipoprotein(a) in Patients With Premature Coronary Artery DiseaseDiana N Vikulova, Mark Trinder, G B John Mancini, et al.
Journal of the American Heart Association|May 25, 2021
Sex Differences in the Presentation, Treatment, and Outcome of Patients With Familial HypercholesterolemiaNatalia Ryzhaya, Lubomira Cermakova, Mark Trinder, et al.
Journal of Clinical Lipidology|November 19, 2017
Increased prevalence of clinical and subclinical atherosclerosis in patients with damaging mutations in ABCA1 or APOA1Omar Abdel-Razek, Singh N Sadananda, Xuan Li, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 24, 2003
Efflux and atherosclerosis: the clinical and biochemical impact of variations in the ABCA1 geneRoshni R Singaraja, Liam R Brunham, Henk Visscher, et al.
CJC Open|November 25, 2024
Genetic Testing for Familial Hypercholesterolemia: The Current State of Its Implementation in CanadaAdam I Kramer, Susan Christian, Kirsten Bartels, et al.
Stem Cell Reports|April 1, 2022
RARG S427L attenuates the DNA repair response to doxorubicin in induced pluripotent stem cell-derived cardiomyocytesHaojun Huang, Effimia Christidi, Sanam Shafaattalab, et al.
Journal of Clinical Lipidology|September 12, 2025
Extreme lipoprotein(a) is a cardiovascular risk equivalent in heterozygous familial hypercholesterolemiaMartine Paquette, Bertrand Cariou, Simon-Pierre Guay, et al.
JACC. Advances|June 28, 2024
Estimating the Prevalence of Hypercholesterolemia in Indigenous Populations: A Systematic Review and Meta-AnalysisRylan K McCallum, Adam I Kramer, Miles Marchand, et al.
Pageof 16

Showing results (51-60 of 156) with videos related to

Sort By:
Pageof 16
European Heart Journal|August 28, 2023
Recommendations for statin management in primary prevention: disparities among international risk scoresG B John Mancini, Arnold Ryomoto, Eunice Yeoh, et al.
Cardiovascular Research|June 8, 2018
Role of genetics in the prediction of statin-associated muscle symptoms and optimization of statin use and adherenceLiam R Brunham, Steven Baker, Andrew Mammen, et al.
The Canadian Journal of Cardiology|August 29, 2021
Familial Hypercholesterolemia, Familial Combined Hyperlipidemia, and Elevated Lipoprotein(a) in Patients With Premature Coronary Artery DiseaseDiana N Vikulova, Mark Trinder, G B John Mancini, et al.
Journal of the American Heart Association|May 25, 2021
Sex Differences in the Presentation, Treatment, and Outcome of Patients With Familial HypercholesterolemiaNatalia Ryzhaya, Lubomira Cermakova, Mark Trinder, et al.
Journal of Clinical Lipidology|November 19, 2017
Increased prevalence of clinical and subclinical atherosclerosis in patients with damaging mutations in ABCA1 or APOA1Omar Abdel-Razek, Singh N Sadananda, Xuan Li, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 24, 2003
Efflux and atherosclerosis: the clinical and biochemical impact of variations in the ABCA1 geneRoshni R Singaraja, Liam R Brunham, Henk Visscher, et al.
CJC Open|November 25, 2024
Genetic Testing for Familial Hypercholesterolemia: The Current State of Its Implementation in CanadaAdam I Kramer, Susan Christian, Kirsten Bartels, et al.
Stem Cell Reports|April 1, 2022
RARG S427L attenuates the DNA repair response to doxorubicin in induced pluripotent stem cell-derived cardiomyocytesHaojun Huang, Effimia Christidi, Sanam Shafaattalab, et al.
Journal of Clinical Lipidology|September 12, 2025
Extreme lipoprotein(a) is a cardiovascular risk equivalent in heterozygous familial hypercholesterolemiaMartine Paquette, Bertrand Cariou, Simon-Pierre Guay, et al.
JACC. Advances|June 28, 2024
Estimating the Prevalence of Hypercholesterolemia in Indigenous Populations: A Systematic Review and Meta-AnalysisRylan K McCallum, Adam I Kramer, Miles Marchand, et al.
Pageof 16